Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Hepatocellular Carcinoma
- 17 January 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 13 (2), 159-167
- https://doi.org/10.1245/aso.2006.11.035
Abstract
Hepatoma-derived growth factor (HDGF) is involved in hepatocarcinogenesis, as well as in liver development and regeneration. This study investigated the correlation of HDGF expression with differentiation and prognosis of hepatocellular carcinoma (HCC). HDGF expression in 100 patients with HCC (81 men and 19 women) with ages ranging from 34 to 81 years (median, 61 years) receiving surgical treatment was analyzed by immunohistochemistry. HDGF messenger RNA expression was evaluated in 10 cases by reverse transcription-polymerase chain reaction. The immunostaining pattern in HCCs was categorized as a positive HDGF index (showing positive staining in >90% of tumor cells in both nucleus and cytoplasm) or a negative HDGF index (all others). Twenty-seven cases (27%) showed a positive and 73 (73%) showed a negative HDGF index. HDGF messenger RNA expression was significantly higher in four cases with a positive HDGF index than in six with a negative index. Cases with well-differentiated histological characteristics showed a higher rate of positive HDGF index than those with a poorly differentiated subtype. Univariate and multivariate analysis revealed significantly poorer disease-free and overall survivals in patients with a positive HDGF index compared with patients with a negative index. These findings suggest the potential utility of HDGF immunohistochemistry in determining the prognosis of HCC.Keywords
This publication has 25 references indexed in Scilit:
- Simplified Staging for Hepatocellular CarcinomaJournal of Clinical Oncology, 2002
- Hepatoma-derived Growth Factor Stimulates Cell Growth after Translocation to the Nucleus by Nuclear Localization SignalsJournal of Biological Chemistry, 2002
- Nuclear Targeting Is Required for Hepatoma-derived Growth Factor-stimulated Mitogenesis in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2001
- Improving Survival Results After Resection of Hepatocellular Carcinoma: A Prospective Study of 377 Patients Over 10 YearsAnnals of Surgery, 2001
- An Analysis of 412 Cases of Hepatocellular Carcinoma at a Western CenterAnnals of Surgery, 1999
- Long term prognosis after hepatectomy for hepatocellular carcinomaCancer, 1998
- Prognostic significance of pathological and biological factors in hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 1998
- Hepatoma-Derived Growth Factor Belongs to a Gene Family in Mice Showing Significant Homology in the Amino TerminusBiochemical and Biophysical Research Communications, 1997
- Hepatic Resection for Hepatocellular Carcinoma An Audit of 343 PatientsAnnals of Surgery, 1995
- Partial purification and characterization of human hepatoma-derived growth factorClinica Chimica Acta; International Journal of Clinical Chemistry, 1989